Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Hofer, D; Raíces, M; Schauenstein, K; Porta, S; Korsatko, W; Hagmüller, K; Zaninovich, A.
The in vivo effects of beta-3-receptor agonist CGP-12177 on thyroxine deiodination in cold-exposed, sympathectomized rat brown fat.
Eur J Endocrinol. 2000; 143(2):273-277 Doi: 10.1530/eje.0.1430273 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Porta Sepp
Schauenstein Konrad
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
OBJECTIVE: The effects of the beta-3-receptor agonist CGP-12177 on thyroxine (T4) deiodination in sympathectomized (SX) interscapular brown adipose tissue (BAT) were assessed in 300 g body weight (BW) Wistar rats. DESIGN: Seven days after SX, groups of rats were implanted s.c. with pellets containing 5mg CGP-12177 or 5mg norepinephrine (NE) and were immediately placed at 4 degrees C for 24h. Other SX groups were injected with CGP-12177 or NE 1mg/kg BW i. p. and placed in the cold for 4h. The latter group was injected, in addition, with prazosin 0.4 mg/100g BW i.p. or propranolol 0.5mg/100g BW i.p. 15 min before and 2h after the administration of CGP-12177 or NE. METHODS: Two hours after the last injection of prazosin or propranolol, animals were killed and BAT was removed, homogenized and centrifuged at 500 g for 10 min at 4 degrees C. The infranatants were incubated during 60 min in the presence of dithiothreitol and 1 microCi [(125)I]T4. Aliquots were chromatographed on paper for the measurement of [(125)I]T4 and its deiodinated subproducts. RESULTS: CGP-12177 restored normal T4 deiodination in SX BAT from both groups, but NE was slightly more effective. Propranolol, although not prazosin, blocked the CGP-12177 effects. Contrariwise, the NE-induced rise in deiodination was blocked by prazosin and to a lesser extent by propranolol. CONCLUSIONS: The results indicate that CGP-12177 stimulated the in vivo activation of 5'-deiodinase type II activity predominantly via beta-3-receptor, without participation of alpha-1-receptors.
Find related publications in this database (using NLM MeSH Indexing)
Adipose Tissue, Brown - drug effects
Adrenergic alpha-Antagonists - pharmacology
Adrenergic beta-Agonists - pharmacology
Adrenergic beta-Antagonists - pharmacology
Animals - pharmacology
Cold - pharmacology
Drug Implants - pharmacology
Enzyme Activation - drug effects
Iodide Peroxidase - metabolism
Iodine - metabolism
Iodine Radioisotopes - metabolism
Male - metabolism
Norepinephrine - pharmacology
Prazosin - pharmacology
Propanolamines - administration and dosage
Propranolol - pharmacology
Rats - pharmacology
Rats, Wistar - pharmacology
Sympathectomy - pharmacology
Thyroxine - metabolism

© Med Uni GrazImprint